{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:47:21Z","timestamp":1770511641625,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Zoonoses and Public Health"],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Adverse events can occur after rabies post\u2010exposure prophylaxis (<jats:styled-content style=\"fixed-case\">PEP<\/jats:styled-content>), and linkage to causality is often difficult to determine. We report a case of recurrent temporary paralysis that began immediately after the initiation of rabies <jats:styled-content style=\"fixed-case\">PEP<\/jats:styled-content> in a man exposed to a bat. The recurrent temporary paralysis first occurred in the patient after his initial dose and then again after day 3 of his rabies <jats:styled-content style=\"fixed-case\">PEP<\/jats:styled-content>. The <jats:styled-content style=\"fixed-case\">PEP<\/jats:styled-content> was terminated prior to a serologic response. The patient continued to experience numerous discrete episodes of temporary paralysis for over two years.<\/jats:p>","DOI":"10.1111\/zph.12143","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T10:48:28Z","timestamp":1404470908000},"page":"222-227","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent Temporary Paralysis Reported After Human Rabies Post\u2010Exposure Prophylaxis"],"prefix":"10.1111","volume":"62","author":[{"given":"V. M.","family":"Dato","sequence":"first","affiliation":[{"name":"Pennsylvania Department of Health Bureau of Epidemiology Harrisburg PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. R.","family":"Campagnolo","sequence":"additional","affiliation":[{"name":"Pennsylvania Department of Health Bureau of Epidemiology Harrisburg PA USA"},{"name":"Centers for Disease Control and Prevention Office of Public Health Preparedness and Response Office of Science and Public Health Practice Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. U.","family":"Shah","sequence":"additional","affiliation":[{"name":"Kentuckyone Health Jewish Hospital Louisville KY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Bellush","sequence":"additional","affiliation":[{"name":"Excela Health Westmoreland Hospital Greensburg PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Rupprecht","sequence":"additional","affiliation":[{"name":"The Global Alliance for Rabies Control Manhattan KS USA"},{"name":"Ross University School of Veterinary Medicine Basseterre St. Kitts West Indies"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"19","volume-title":"The History of Rabies: In Rabies","author":"Baer G. M.","year":"2007"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922809332689"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330230048030"},{"key":"e_1_2_6_5_1","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs D. J.","year":"2000","journal-title":"Bull. World Health Organ."},{"key":"e_1_2_6_6_1","first-page":"12","article-title":"Availability of a new rabies vaccine for human use","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR"},{"key":"e_1_2_6_7_1","unstructured":"CDC 2008:Human rabies prevention\u2014United States 2008: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 57(No. RR\u20103)."},{"key":"e_1_2_6_8_1","volume-title":"Human Rabies","author":"CDC","year":"2011"},{"key":"e_1_2_6_9_1","unstructured":"CDC 2013a:Human rabies: cases of rabies in human beings in the United States by circumstances of exposure and rabies virus variant 1995\u20102011. Available at:http:\/\/www.cdc.gov\/rabies\/location\/usa\/surveillance\/human_rabies.html(accessed 2 April 2013)."},{"key":"e_1_2_6_10_1","unstructured":"CDC 2013b:Doctors: adverse reaction \u2013 rabies. Available at:http:\/\/www.cdc.gov\/rabies\/specific_groups\/doctors\/adverse_reaction.html(accessed 26 March 2013)."},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.005"},{"key":"e_1_2_6_12_1","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet]","author":"Jurkat\u2010Rott K.","year":"1993"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/13550280590900427"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.300030205"},{"key":"e_1_2_6_15_1","first-page":"315","article-title":"The acetylcholine receptor as a cellular receptor for rabies virus","volume":"56","author":"Lentz T. L.","year":"1983","journal-title":"Yale J. Biol. Med."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2011.05.021"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a018041"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6277-7"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.102"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.029"},{"key":"e_1_2_6_21_1","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet]","author":"Sternberg D.","year":"1993"},{"key":"e_1_2_6_22_1","unstructured":"WHO 2010:Grading of scientific evidence. Table III: Safety of cell\u2010culture\u2010based rabies vaccines. Available at:http:\/\/www.who.int\/immunization\/rabies_grad_safety.pdf. (accessed 1 April 2013)."},{"key":"e_1_2_6_23_1","unstructured":"WHO 2012a:Biologicals; Rabies. Available at:http:\/\/www.who.int\/biologicals\/areas\/vaccines\/rabies\/en(accessed 27 July 2012)."},{"key":"e_1_2_6_24_1","unstructured":"WHO 2012b:Rabies Vaccine: Observed Rate of Vaccine Reactions. Available at:http:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/Rabies_Vaccine_rates_information_sheet.pdf. (accessed 1 April 2013)."},{"key":"e_1_2_6_25_1","first-page":"99","volume-title":"Rhabdomyoviruses","author":"Wiktor T. H.","year":"1980"}],"container-title":["Zoonoses and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fzph.12143","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/zph.12143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:32:06Z","timestamp":1696192326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/zph.12143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1111\/zph.12143"],"URL":"https:\/\/doi.org\/10.1111\/zph.12143","archive":["Portico"],"relation":{},"ISSN":["1863-1959","1863-2378"],"issn-type":[{"value":"1863-1959","type":"print"},{"value":"1863-2378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]}}}